companies / glycoera-com
Generated UTC · publication cutoff 2026-11-09
Insufficient cited evidence for a two-sentence summary.
verified=2026-05-21 json
| total_raised | 130,000,000130.0M | ○ |
|---|---|---|
| founded | null | |
| hq | CH | |
| industry | unknown | |
| stage | series-b+ |
GlycoEra develops biologics that selectively degrade circulating proteins, particularly the pathogenic IgG4 autoantibodies driving autoimmune disease. It targets patients who benefit from early, precise intervention, led by GE8820. Unlike broad immunosuppressants, it degrades targets deeply without dampening the wider immune system.
No cited completed company acquisition recorded.
Dated disclosures. Customer relationships and classifications are historical; ARR is separate from revenue.
No cited disclosure recorded: named customer, disclosed revenue, ARR, count, B2B / B2C, sector, go-to-market.
No cited valuation with an explicit basis is recorded.
Historical post-money / actual annual or stated TTM revenue. Same currency; economic valuation date within 90 days of revenue period end, inclusive. No FX, ARR, annualized revenue, estimates or projections. Conflicts and ambiguous ties are withheld.
No qualifying pair recorded.
| date | type | amount | lead | src |
|---|---|---|---|---|
| 2025-05-01 | series-b | 130,000,000130.0M | null | ○ |
Cloudflare, WordPress 6.9.4, Magnific Popup 4.9.1, GoDaddy CoBlocks, Slick, jQuery Migrate 3.4.1, Cloudflare Bot Management, Contact Form 7 5.9.3, web-vitals, WP Job Openings 3.4.6, Bold Page Builder, PHP
| fact | status | src |
|---|---|---|
| Series B, $130.0M | attributed | ○ |
| existence | self-reported | WEB |
| description | self-reported | WEB |